GenScript ProBio Partners with Bio Immunitas for hRPP Platform
Nanjing-based GenScript ProBio, a leading biologics Contract Development and Manufacturing Organization (CDMO), has formed a...
Deals
Hemay Pharma Completes Series D Financing for Autoimmune and Oncology Drugs
China-based Ganzhou Hemay Pharmaceutical Co., Ltd, an innovative drug developer focused on autoimmune diseases and...
Neurodawn Completes Series A+ Financing for CNS Drug Development
Neurodawn Pharmaceutical Co., Ltd, a central nervous system (CNS) drug developer based in Nanjing, has...
Eyebright Medical Gains SIX Swiss Exchange Approval for GDR Offering
Beijing-based ophthalmic device maker Eyebright Medical Technology Co., Ltd (SHA: 688050) has announced receiving conditional...
Teddy Clinical Research Lab Partners with Cerba Research for Global Services
China-based Teddy Clinical Research Laboratory Limited, a joint venture (JV) between Dian Diagnostics (SHE: 300244)...
Junshi Biosciences’ COVID-19 Therapy Faces Supply Issues, Partners with Sihuan Pharma
Junshi Biosciences’ (HKG: 1877, SHA: 688180) COVID-19 therapy JT001 (VV116) appears to be facing supply...
Macrolux Secures Series A Funding for Endoscopy Solutions
Macrolux, an endoscopy intervention solutions provider based in Shenzhen, has reportedly raised close to RMB...
Hua Medicine Receives Milestone Payment from Bayer for Dorzagliatin
China-based Hua Medicine has announced receiving a RMB 400 million (USD 59 million) milestone payment...
Asia Regenerative Medicine Raises Pre-Series A+ Funding for Bioartificial Organs
Shenzhen-based Asia Regenerative Medicine (ARM) has reportedly raised “tens of millions” of renminbi in a...
Beijing Smart Beam Raises Series A+ Funding for CT X-Ray Tube Development
Beijing Smart Beam Technology, a leading vacuum electronic device maker, has reportedly raised “tens of...
Asieris Partners with ReviR Therapeutics for Urogenital Cancer Research
China-based urogenital cancer specialist Jiangsu Yahong Meditech Co., Ltd (Asieris, SHA: 688176) has struck a...
Lifetech Partners with Jenscare for Structural Heart Disease Devices
China-based Lifetech Scientific Corporation (HKG: 1302) has announced a partnership agreement with compatriot firm Jenscare...
AnHeart Therapeutics Partners with Guardant Health for Taletrectinib Diagnostics
Sino-US biopharma AnHeart Therapeutics and US precision oncology firm Guardant Health Inc. (NASDAQ: GH) have...
Forlong Biotechnology Secures Series A Funding for Protein Drug Development
Forlong Biotechnology, a synthetic immunology-driven protein drug developer based in Suzhou, has reportedly raised upwards...
Zhimeng Biopharma Signs Global Licensing Deal with GSK for TLR8 Agonist CB06
Shanghai Zhimeng Biopharma Inc. has announced the signing of a global licensing agreement with UK...
Haisco Pharmaceutical Announces Public Offering for Clinical Studies
China-based Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) is set to make another public offering...
Ji Xing Pharmaceuticals Acquires Global Rights to PhaseBio’s PB6440
Shanghai-based Ji Xing Pharmaceuticals, backed by RTW Investments, has announced a deal to obtain global...
Zhejiang Gongdong to Acquire Trademark Plastics for Overseas Expansion
China-based Zhejiang Gongdong Medical Technology Co., Ltd is set to acquire core assets of US...
Shanghai Weimu Medical Raises Pre-Series A+ Funding for Clinical Development
China-based high-end interventional device maker Shanghai Weimu Medical Technology Co., Ltd has reportedly raised “tens...
MicroPort Endovascular Plans RMB 2.55 Billion Private Placement
China-based Shanghai MicroPort Endovascular MedTech Co., Ltd (SHA: 688016) plans to raise up to RMB...